Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David BarbieInvestigational New Drugs|August 15, 2018
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinomaKimmie Ng, Andrew Hendifar, Alexander Starodub, et al.Clinical Lung Cancer|January 3, 2025
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic CarcinomaJennifer A Marks, Jaeil Ahn, Joshua E Reuss, et al.Blood Advances|December 4, 2018
The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapySuhu Liu, Anna E Marneth, Gabriela Alexe, et al.Biorxiv : the Preprint Server for Biology|December 11, 2023
Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1RHuu Tuan Nguyen, Nadia Gurvich, Mark Robert Gillrie, et al.Biomaterials|August 17, 2024
Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1RHuu Tuan Nguyen, Ellen L Kan, Mouhita Humayun, et al.Cell Death and Differentiation|December 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanismsMaria Davern, Cole J Turner, Daryl Griffin, et al.Research Square|April 2, 2024
Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapyShaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.Nature Biotechnology|October 4, 2024
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responsesShaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.Nature Communications|January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironmentBassel Alsaed, Linh Lin, Jieun Son, et al.Pageof 2